-+ 0.00%
-+ 0.00%
-+ 0.00%

Keros Therapeutics launches $5 million share buyback program

PUBT·09/08/2026 20:01:13
Listen to the news
Keros Therapeutics launches $5 million share buyback program
  • Keros Therapeutics authorized a USD 5 million share repurchase program following a USD 20 million elritercept milestone payment from Takeda.
  • Buybacks may occur from time to time in the open market or through other permitted methods.
  • Repurchase timing, size hinge on share price, market conditions, contractual limits, other factors.
  • Program can be modified, suspended, or terminated at any time.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Keros Therapeutics Inc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609081601PRIMZONEFULLFEED9822923) on September 08, 2026, and is solely responsible for the information contained therein.